MedTrace Logo

Long-term Effect of a 3-month Supplementation With Holo-BLG on House Dust Mite Induced Allergic Rhinoconjunctivitis

NCT04872868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-04-22

No results posted yet for this study

Summary

The aim of the study is to investigate the long-term effect of a lozenge containing beta-lactoglobulin (BLG), iron, retinoic acid, zinc and polyphenols (holo-BLG) in people with allergic rhinoconjunctivitis caused by house dust mites and the associated symptoms (symptom type and severity) during exposure to house dust mites in an Allergen Exposure Chamber (AEC).

In particular, the study aims to evaluate whether the improvements in symptoms of house dust mite-induced rhinoconjunctivitis observed after 3 months of supplementation with holo-BLG can still be detected 7 to 8 months after the last intake.

Conditions

  • Dust Mite Allergy
  • Allergic Rhinitis

Sponsors & Collaborators

  • Bencard Allergie GmbH

    collaborator OTHER

  • Ecarf Institute GmbH

    lead OTHER

Principal Investigators

  • Sylvia Becker · Ecarf Institute GmbH

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2021-02-12
Completion
2021-02-12

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872868 on ClinicalTrials.gov